JBCHEPHARM - IntraDay Trade Analysis with Live Signals

Last Updated Time : 19 Sept 25, 2:16 pm

IntraDay Trade Rating: 3.6

📊 Intraday Trade Analysis for JBCHEPHARM

✅ Strengths

Strong Fundamentals: ROCE (25.9%) and ROE (20.2%) reflect solid operational and financial efficiency.

Zero Debt: Debt-to-equity ratio of 0.00 makes it a low-risk candidate for short-term trades.

EPS (₹43.5) and PAT Growth (+14.2%): Indicate consistent earnings performance.

Volume Above Average: Current volume (1.37L) exceeds 1-week average (1.01L), showing active participation.

DII Holding Increase (+0.91%): Domestic institutions are accumulating.

⚠️ Weaknesses

MACD (-5.87): Bearish crossover suggests short-term downside pressure.

RSI (43.6): Weak momentum, hovering near oversold territory.

Price Below 50-DMA (₹1,705) and near 200-DMA (₹1,699)**: Indicates resistance overhead.

FII Holding Decline (-0.53%): Mild foreign investor pullback.

High P/E (39.1) vs Industry PE (33.4): Slightly overvalued.

52w Index (55.8%): Underperforming relative to yearly high (₹1,998).

🎯 Intraday Strategy

📈 If Entering Fresh Today

Optimal Buy Zone: ₹1,685–₹1,688 (on dips near VWAP or minor support)

Profit Targets

Primary Target: ₹1,705 (50-DMA resistance)

Secondary Target: ₹1,715–₹1,720 (if momentum improves)

Stop Loss: ₹1,670 (below recent support and psychological level)

📉 If Already Holding Today

Exit on Weakness

If price breaks below ₹1,675 with rising volume and bearish candles.

RSI drops below 40 or MACD widens negatively — signals fading momentum.

Exit on Strength

If price hits ₹1,705–₹1,720 and RSI crosses 65 with declining volume — consider booking profits.

Watch for bearish divergence or reversal candles near resistance.

🧠 Final Take

JBCHEPHARM offers a moderately bullish intraday setup with strong fundamentals and decent volume. However, technical indicators suggest limited upside and resistance overhead. Best suited for nimble traders with tight stop-losses and momentum tracking.

Edit in a page